ACE OncoCast
The official podcast feed of ACE Oncology. ACE provides evidence-based, high-quality independent medical education solutions that support clinicians in making up-to-date, appropriate treatment decisions. Listen to discussions among experts and stay informed on new data and best practices in the care of patients with cancer. The information in this podcast is provided for informational and educational purposes only.
Podcasting since 2021 • 50 episodes
ACE OncoCast
Latest Episodes
Expert Interview of Dr Carballo: The Role of Radiotherapy for MIBC Patients
Natalia Carballo, MDSanitas Hospitals/Atrys HealthMadrid, SpainThe therapeutic landscape for urothelial cancer (UC) has undergone significant transformation in recent years, with the addition of PD-1/PD-L1 targeting immune...
•
Season 12
•
Episode 4
•
5:25
Expert Interview of Dr Guerrero: Optimal Management for NMIBC and MIBC Patients from a Surgical Perspective
Félix Guerrero-Ramos, MD, PhD, FEBUHospital Doce de OctubreMadrid, SpainThe therapeutic landscape for urothelial cancer (UC) has undergone significant transformation in recent years, with the addition of PD-1/PD-L1 targeti...
•
Season 12
•
Episode 3
•
16:54
Expert Interview of Dr Real: Molecular Pathology and Biology of Urothelial Cancer
Francisco X. Real, MD, PhDNational Cancer Research CenterMadrid, SpainThe therapeutic landscape for urothelial cancer (UC) has undergone significant transformation in recent years, with the addition of PD-1/PD-L1 targeting...
•
Season 12
•
Episode 2
•
11:28
Expert Interview of Dr Enrique Grande: Highlights of the Evolving Therapeutic Landscape in Urothelial Cancer
Enrique Grande, MD, MSc, PhD Quirónsalud MadridMadrid, SpainThe therapeutic landscape for urothelial cancer (UC) has undergone significant transformation in recent years, with the addition of PD-1/PD-L1 targeting immu...
•
Season 12
•
Episode 1
•
20:09
Expert Interview of Specialist Insights in Urothelial Cancer: Optimal Management for NMIBC and MIBC Patients (2 of 2)
Natalia Carballo, MDMD Anderson Cancer Center MadridMadrid, SpainThe therapeutic landscape for urothelial cancer has undergone significant transformation in recent years, with the addition of PD1/PD-L1 targeting immune che...
•
Season 11
•
Episode 2
•
4:10